IP Verse

Type Ii Anti-Cd20 Antibody For Reducing Formation Of Anti-Drug Antibodies

Patent No. EP3387015 (titled "Type Ii Anti-Cd20 Antibody For Reducing Formation Of Anti-Drug Antibodies") was filed by F Hoffmann LA Roche on Dec 6, 2016. The application was issued on Oct 27, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANJul 26, 2022GREAVES BREWSTER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3387015

F HOFFMANN LA ROCHE
Application Number
EP16810283A
Filing Date
Dec 6, 2016
Status
Granted And Under Opposition
Sep 24, 2021
Publication Date
Oct 27, 2021
External Links
Slate, Register , Google Patents